These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
402 related articles for article (PubMed ID: 32245225)
41. Independent comparison study of six different electronic tongues applied for pharmaceutical analysis. Pein M; Kirsanov D; Ciosek P; del Valle M; Yaroshenko I; Wesoły M; Zabadaj M; Gonzalez-Calabuig A; Wróblewski W; Legin A J Pharm Biomed Anal; 2015 Oct; 114():321-9. PubMed ID: 26099261 [TBL] [Abstract][Full Text] [Related]
42. Green and sustainable chemical synthesis using flow microreactors. Yoshida J; Kim H; Nagaki A ChemSusChem; 2011 Mar; 4(3):331-40. PubMed ID: 21394921 [TBL] [Abstract][Full Text] [Related]
43. Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines? Almarsson O; Zaworotko MJ Chem Commun (Camb); 2004 Sep; (17):1889-96. PubMed ID: 15340589 [TBL] [Abstract][Full Text] [Related]
44. Microreactors as new tools for drug discovery and development. Wong-Hawkes SY; Matteo JC; Warrington BH; White JD Ernst Schering Found Symp Proc; 2006; (3):39-55. PubMed ID: 17695709 [TBL] [Abstract][Full Text] [Related]
45. Organic synthesis: The robo-chemist. Peplow M Nature; 2014 Aug; 512(7512):20-2. PubMed ID: 25100466 [No Abstract] [Full Text] [Related]
49. Frontiers in GPCR research. Stark H Arch Pharm (Weinheim); 2005 Jun; 338(5-6):207. PubMed ID: 15962349 [No Abstract] [Full Text] [Related]
50. Pharmaceutical process chemistry: evolution of a contemporary data-rich laboratory environment. Caron S; Thomson NM J Org Chem; 2015 Mar; 80(6):2943-58. PubMed ID: 25635809 [TBL] [Abstract][Full Text] [Related]
51. Commentary: contribution of pathology to drug research and development in the next decade. Harleman JH Toxicol Pathol; 1999; 27(4):479-80. PubMed ID: 10485834 [No Abstract] [Full Text] [Related]
52. Development of an automation system for a tablet coater. Ruotsalainen M; Heinämäki J; Rantanen J; Yliruusi J AAPS PharmSciTech; 2002; 3(2):E14. PubMed ID: 12916951 [TBL] [Abstract][Full Text] [Related]
53. High-throughput screening of enzyme inhibition using an inhibitor gradient generated in a microchannel. Garcia E; Hasenbank MS; Finlayson B; Yager P Lab Chip; 2007 Feb; 7(2):249-55. PubMed ID: 17268628 [TBL] [Abstract][Full Text] [Related]
54. Solid supported reagents in multi-step flow synthesis. Baxendale IR; Ley SV Ernst Schering Found Symp Proc; 2006; (3):151-85. PubMed ID: 17695715 [TBL] [Abstract][Full Text] [Related]
55. Anticancer drug discovery and development. Colotta F Adv Exp Med Biol; 2008; 610():19-42. PubMed ID: 18593013 [No Abstract] [Full Text] [Related]
57. Top of the form. Brown M Drug Discov Today; 2002 Oct; 7(20):1026-7. PubMed ID: 12546885 [No Abstract] [Full Text] [Related]
58. At the flick of a switch: epigenetic drugs. Pray L Chem Biol; 2008 Jul; 15(7):640-1. PubMed ID: 18634998 [No Abstract] [Full Text] [Related]
59. [New methods in pharmaceutical research: combinatorial chemistry and high throughput screening]. Schirlin D; Galvan M; Le Fur G Bull Acad Natl Med; 2007; 191(4-5):727-36; discussion 736-7. PubMed ID: 18225426 [TBL] [Abstract][Full Text] [Related]
60. Microfluidic-controlled manufacture of liposomes for the solubilisation of a poorly water soluble drug. Kastner E; Verma V; Lowry D; Perrie Y Int J Pharm; 2015 May; 485(1-2):122-30. PubMed ID: 25725309 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]